Return to Mefloquine homepage. The following is a summary of the first case conference regarding the Mefloquine Mass Tort. On August 13, 2019, the parties attended the first Case Management Conference before Prothonotary Furlanetto of the Federal Court. The purpose of this attendance was to introduce the cases to the Court and to work out scheduling … Read More
On August 1, 2019, Justice Perell of the Ontario Superior Court of Justice approved a $5 million dollar settlement in Houle v. St. Jude.
John Dowe is a veteran working with HSH to bring justice to veterans affected by Mefloquine across the country.
As an update to our ongoing Allergen lawsuit, this week the company issued a global recall of the textured breast implants, the focus of our legal action.
Howie Sacks and Henry LLP has partnered with Beyond Law LLP to pursue individual mass tort actions on behalf of women and their families who have suffered injury due to Allergan breast implants.
HSH Partner Paul Miller will be speaking at this year’s Veterans Mefloquine Rally. The rally’s purpose is to provide information to veterans, spouses and families on protests and other ongoing actions in the fight to expose government inaction and complacency in the licencing of the anti Malarial drug Mefloquine. Details Date: Sep 19th 2019Time: 1:00 pm … Read More
If you or a loved one received an Allergan breast implant and diagnosed with BIA-ALCL you will be interested in watching this webinar to answer questions about this lawsuit.
Howie, Sacks & Henry LLP (HSH) anticipates filing lawsuits for individuals who have retained us within the next few months. We know that there are many women across Canada who have suffered side effects due to Essure who have not yet contacted us. We encourage anyone who wishes to be part of the mass tort … Read More
Three separate lawsuits have been filed in the Federal Court by a total of 8 individuals against the Government of Canada alleging that the Government, through the Department of National Defence, ordered members of the Canadian Armed Forces to take an anti-malarial medication known as “Mefloquine” without adequately informing CAF Members of the severe adverse … Read More
A national class action has been certified against St. Jude Medical, Inc. and St. Jude Medical Canada, Inc. for the purpose of effecting a CAD $5 million settlement of the class action.